Coverage
Filings
| Filing | Date |
|---|---|
| Group financial statement for 2019 | 23 Jan 2020 |
| Updated financial calendar 2020 | 23 Jan 2020 |
| Trading by management and close relations of management | 23 Jan 2020 |
| Annual report 2019 | 23 Jan 2020 |
| Candidates proposed for the Board of Directors | 11 Dec 2019 |
| Transactions under Novozymes’ stock buyback program | 18 Nov 2019 |
| Transactions under Novozymes’ stock buyback program | 11 Nov 2019 |
| Trading by management and close relations of management |
Danish biosolutions company Novonesis on Thursday raised its full-year sales forecast after reporting strong growth for the first nine months of the year, citing a robust performance across its markets.
Novonesis on Wednesday laid out new long-term financial targets, aiming to accelerate sales growth and expand profit margins through 2030 as part of its new ‘GROW’ strategy.
Novonesis has successfully completed its acquisition of dsm-firmenich's share of the Feed Enzyme Alliance, the company announced.
| 5 Nov 2019 |
| Transactions under Novozymes’ stock buyback program | 4 Nov 2019 |
| Ester Baiget appointed new CEO of Novozymes | 30 Oct 2019 |
| Transactions under Novozymes’ stock buyback program | 28 Oct 2019 |
| Financial calendar 2020 | 25 Oct 2019 |